Holocene Advisors
ABBV icon

Holocene Advisors’s AbbVie ABBV Stock Holding History

Holocene Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-791,500
Closed -$123M – 693
2023
Q4 		$123M Buy
+791,500
New +$115M 0.48% 69
2022
Q1 		– Sell
-2,216,200
Closed -$300M – 851
2021
Q4 		$300M Buy
2,216,200
+263,200
+13% +$31.1M 1.56% 4
2021
Q3 		$211M Buy
1,953,000
+1,034,300
+113% +$118M 1.14% 11
2021
Q2 		$103M Buy
918,700
+18,700
+2% +$2.11M 0.58% 53
2021
Q1 		$97.4M Buy
+900,000
New +$96.3M 0.61% 43

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Holocene Advisors's ABBV Position: Q3 2025 in Review

Holocene Advisors sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 3,270 shares — an estimated $607K sold.

Holocene Advisors first reported a position in ABBV in Q2 2020 and held it in 13 quarters. The position peaked at $257M in Q4 2023. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Holocene Advisors reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Holocene Advisors sold 3,270 AbbVie shares in Q3 2025, an estimated $607K.
  • Holocene Advisors first reported a position in AbbVie in Q2 2020 and held it in 13 quarters.
  • Holocene Advisors's AbbVie position peaked at $257M in Q4 2023.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Holocene Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.